Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies

OBJECTIVE: To define the clinicopathologic features and diagnostic utility associated with anti‐cytosolic 5′‐nucleotidase 1A (NT5C1A) antibody seropositivity in idiopathic inflammatory myopathies (IIMs). METHODS: Anti‐NT5C1A antibody status was clinically tested between 2014 and 2019 in the Washingt...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikenaga, Chiseko, Findlay, Andrew R., Goyal, Namita A., Robinson, Sarah, Cauchi, Jonathan, Hussain, Yessar, Wang, Leo H., Kershen, Joshua C., Beson, Brent A., Wallendorf, Michael, Bucelli, Robert C., Mozaffar, Tahseen, Pestronk, Alan, Weihl, Conrad C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951108/
https://www.ncbi.nlm.nih.gov/pubmed/33556224
http://dx.doi.org/10.1002/acn3.51294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951108/
https://www.ncbi.nlm.nih.gov/pubmed/33556224
http://dx.doi.org/10.1002/acn3.51294

Ejemplares similares